[CSELS] National Notifiable Diseases Surveillance System (NNDSS)
Revision of a currently approved collection
No
Regular
Approved without change
03/23/2023
02/14/2023
Previous terms continue. Approved with the understanding that changes in data elements will be submitted as nonsub changes and larger revisions, including methodology, methods of administration, or the addition of conditions will be submitted as revisions. CDC will work with their OIRA desk officer to brief upcoming changes and determine the appropriate pathways for submission
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
03/31/2026
36 Months From Approved
07/31/2025
7,276
0
7,276
18,594
0
18,495
0
0
838,689
The National Notifiable Diseases Surveillance System (NNDSS) is the nationâs public health surveillance system used to monitor the occurrence and spread of nationally notifiable conditions. Respondents are 60 jurisdictions: public health departments in every U.S. state, New York City, Washington DC, 5 U.S. territories (American Samoa, the Commonwealth of Northern Mariana Islands, Guam, Puerto Rico, and the U.S. Virgin Islands), and 3 freely associated states (the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau).
NNDSS provides the official source of statistics in the United States for nationally notifiable conditions and CDC is the sole repository for these national, population-based data. Recently the NNDSS platform was modernized and expanded as a low-cost, common portal for collecting information on other conditions. Among the thousands of diseases that affect the health of the population, CDC and the Council of State and Territorial Epidemiologists (CSTE) have prioritized the approximately 120 Nationally Notifiable Conditions as those most important for public health monitoring and response.
Changes to NNDSS in this revision include receipt of case notification data for CPO since it is now nationally notifiable, receipt of case notification data for Strongyloidiasis since it is under standardized surveillance, and receipt of disease-specific data elements for Brucellosis, Candida auris, CPO, Carbon Monoxide Poisoning, Hepatitis, Leptospirosis, Melioidosis, and Viral Hemorrhagic Fevers. The overall burden hours increased since the last revision because there were more one-time burdens associated with disease-specific data elements in this revision (161 disease-specific data elements) as compared to the last revision (24 disease-specific data elements). Going forward, there will be a one-time increase in the burden estimates each time new data elements or new conditions are added. The one-time increase in the burden estimates for adding new data elements will continue to be reflected as a separate line in the burden table in an ICR revision or a non-substantive change request.
Note that the change in the total cost burden appears to be very large. However, the change in total cost burden is associated with the change in accounting method. In the past, CDC reported the cost burden for each IC as the wage-equivalents that appear in Section 12.B of the supporting statement. Consistent with the rest of HHS, CDC is now reporting the total from Section 13 in the "burden cost" field for each IC. Section 13 covers nonwage costs (e.g., equipment). As such, costs associated with these ICs are now "zero."
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Att 15 - PRA Burden Statement Screenshot.pdf
Att 14 - Burden Table Calculations_2023.xlsx
0920-0728_NNDSS_Supporting_Statement_B_01202023.docx
Freely Associated States - One-time Addition of Diseases and Data Elements